409 related articles for article (PubMed ID: 20421581)
21. The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus.
Muscal E; Myones BL
Autoimmun Rev; 2007 Mar; 6(4):215-7. PubMed ID: 17317610
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE).
Hermosillo-Romo D; Brey RL
Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):229-44. PubMed ID: 12041951
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
24. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus.
Perricone C; Pendolino M; Olivieri M; Conti F; Valesini G; Alessandri C
Isr Med Assoc J; 2015 Mar; 17(3):171-8. PubMed ID: 25946769
[TBL] [Abstract][Full Text] [Related]
25. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
26. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
27. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
[TBL] [Abstract][Full Text] [Related]
28. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
Kang EH; Shen GQ; Morris R; Metzger A; Lee EY; Lee YJ; Lee EB; Song YW
Lupus; 2008 Jan; 17(1):21-5. PubMed ID: 18089679
[TBL] [Abstract][Full Text] [Related]
30. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
Bosma GP; Rood MJ; Zwinderman AH; Huizinga TW; van Buchem MA
Arthritis Rheum; 2000 Jan; 43(1):48-54. PubMed ID: 10643699
[TBL] [Abstract][Full Text] [Related]
31. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
[TBL] [Abstract][Full Text] [Related]
32. Psychiatric manifestations in systemic lupus erythematosus.
Stojanovich L; Zandman-Goddard G; Pavlovich S; Sikanich N
Autoimmun Rev; 2007 Jun; 6(6):421-6. PubMed ID: 17537389
[TBL] [Abstract][Full Text] [Related]
33. Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model.
Mondal TK; Saha SK; Miller VM; Seegal RF; Lawrence DA
Brain Behav Immun; 2008 Aug; 22(6):949-59. PubMed ID: 18411022
[TBL] [Abstract][Full Text] [Related]
34. Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging.
Bosma GP; Rood MJ; Huizinga TW; de Jong BA; Bollen EL; van Buchem MA
Arthritis Rheum; 2000 Nov; 43(11):2428-36. PubMed ID: 11083265
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence of antiepithelial cell antibody in systemic vasculitis and identification of the target antigen thereof].
Zheng WJ; Tang FL; Zhao Y; Chen H; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3272-6. PubMed ID: 16409818
[TBL] [Abstract][Full Text] [Related]
36. Echolalia as a novel manifestation of neuropsychiatric systemic lupus erythematosus.
Zapor M; Murphy FT; Enzenauer R
South Med J; 2001 Jan; 94(1):70-2. PubMed ID: 11213948
[TBL] [Abstract][Full Text] [Related]
37. Novel brain reactive autoantibodies: prevalence in systemic lupus erythematosus and association with psychoses and seizures.
Tin SK; Xu Q; Thumboo J; Lee LY; Tse C; Fong KY
J Neuroimmunol; 2005 Dec; 169(1-2):153-60. PubMed ID: 16146655
[TBL] [Abstract][Full Text] [Related]
38. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
Kozora E; Arciniegas DB; Filley CM; West SG; Brown M; Miller D; Grimm A; Devore MD; Wingrove C; Zhang L
Arthritis Rheum; 2008 Nov; 59(11):1639-46. PubMed ID: 18975359
[TBL] [Abstract][Full Text] [Related]
39. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
[TBL] [Abstract][Full Text] [Related]
40. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.
Iikuni N; Okamoto H; Yoshio T; Sato E; Kamitsuji S; Iwamoto T; Momohara S; Taniguchi A; Yamanaka H; Minota S; Kamatani N
Ann Rheum Dis; 2006 Feb; 65(2):253-6. PubMed ID: 16410530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]